4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-24-005418
EVP & Chief Medical Officer sold 3,321 shares at $10.24 ($34,006)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip EVP & Chief Medical Officer | 2024-02-16 | Sale 10b5-1 | −3,321 | $10.24 | $34,006 | 264,679 | D |
| Open-market sales · 3,321 sh · avg $10.24 · $34,006 | |||||||
Loading xslF345X05/wk-form4_1708127793.xml…